One emerging problem for onco-gynecologists is the incidence of premenopausal patients
under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to …

Background The gold standard treatment for early-stage endometrial cancer (EC) is
hysterectomy with bilateral salpingo-oophorectomy (BSO) with lymphadenectomy. In …

Endometrial cancer is the most incident gynecological cancer. Lymph node dissemination is
one of the most important factors for the patient's prognosis. Pelvic lymph nodes are the …

Endometrial cancer is one of the most common gynecological malignancies worldwide;
incidences are rising, with 417,367 new cases registered in 2020. Of these, the proportion of …

Radiation therapy (RT) is the standard of care in patients with locoregional or isolated
vaginal recurrence who never underwent irradiation. It is often associated with …

To elucidate the expression profiles, methylation states, and clinicopathological significance
of the PRDM gene family, focusing on the MECOM gene's role in uterine endometrial cancer …

Objective This study was designed to investigate the frequency and clinicopathological
characteristics of POLE-mutated/ultramutated (POLEmut) in endometrial carcinoma (EC) …

Objective To establish a prognostic model for endometrial cancer (EC) that individualizes a
risk and management plan per patient and disease characteristics. Methods A multicenter …

The molecular characterization of endometrial carcinoma (EC) has recently been included in
the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated …

Simple Summary The impact of the molecular signature on the favorable prognosis of
endometrial cancer patients with coexistent adenomyosis is undefined. We aimed to …